October 24, 2018
The Ministry of Health, Labor and Welfare (MHLW) ordered on October 23 a package insert revision for the antiepileptic treatment lamotrigine (original product: Lamictal by GlaxoSmithKline) to add hemophagocytic syndrome to a list of adverse drug reactions (ADRs). Following overseas...read more